TLSI TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery™ (PEDD™) Portfolio for Liver Embolization
Story updates
08:15:34 PM UTC
SquawkNews
TriSalus Life Sciences received FDA 510(k) clearance for TriNav Advance, expanding its Pressure-Enabled Drug Delivery portfolio to small, distal vessels and broader embolization procedures. A limited market release will begin in the coming weeks.Material DetailsContext by AI AnalystThis is an expan…
08:19:10 PM UTC
SquawkNews
TLSI TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery™ (PEDD™) Portfolio for Liver Embolization